AUTL · Autolus Therapeutics plc ADR
United States · RS rating 74 · As of 2026-10-14
| Price | 1.69 USD |
|---|---|
| 1-day change | +4.3% |
| RS rating (overall / 1M / 3M / 12M) | 74 / 22 / 89 / 49 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 33 / 38 / 38 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | +44.4% |
| Sales growth Q/Q | +14.6% |
| Distance from 52-week high | +33.5% |
| Market cap (USD) | $407.2M |